Who is sponsoring NCT04371081?

NCT04371081 is sponsored by Abbott Medical Devices.

What drugs are being tested in NCT04371081?

Interventions in NCT04371081: Amplatzer Piccolo Occluder.

What condition does NCT04371081 study?

NCT04371081 studies Patent Ductus Arteriosus.

Is NCT04371081 still recruiting?

NCT04371081 is currently active, enrolled. Last updated 3 October 2025.

Last reviewed 2025-10-03 · How we verify

NCT04371081

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance

Active, enrolled Last updated 3 October 2025

What this trial tests

trial testing Amplatzer Piccolo Occluder in Patent Ductus Arteriosus in 70 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 April 2020

Primary endpoint
10 September 2025

31 July 2027

Quick facts

Lead sponsor	Abbott Medical Devices
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	70
Start date	1 April 2020
Primary completion	10 September 2025
Estimated completion	31 July 2027
Sites	1 location across Japan

Drugs / interventions tested

Amplatzer Piccolo Occluder

Conditions studied

Patent Ductus Arteriosus — all drugs for Patent Ductus Arteriosus →

Sponsor

Abbott Medical Devices — full company profile →

Who can join

3 Days and older, any sex, with Patent Ductus Arteriosus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this post-marketing clinical use database surveillance is to observe the frequency, type, and degree of adverse device effects and adverse events in order to assure the safety of the medical device, and to collect safety and efficacy information for evaluating the results of its clinical use.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Patent Ductus Arteriosus

Currently open trials in the same condition.

NCT06646250 — NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot · recruiting
NCT05264753 — Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With P · recruiting
NCT03456336 — Management of the PDA Trial · Phase 3 · active not recruiting

Other Abbott Medical Devices trials

Trials by the same sponsor.

NCT07421076 — Grid eXplore Mapping Study · NA · recruiting
NCT07509658 — TriClip Japan Post-Approval Study · recruiting
NCT07361445 — Agilis RF TSP Early Feasibility Study · NA · recruiting
NCT07373353 — A Clinical Evaluation of AMJ-401 · NA · recruiting
NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04371081 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abbott Medical Devices
Last refreshed: 3 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04371081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing